Newest first
New topics page 9
Topics ordered by when they were created rather than by activity. This is where a question that nobody has answered yet is easiest to find — and answering one is the fastest route to a first solution badge.
1,535 topics · page 9 of 40
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Historical amylin analogues and what happened to them
Posting this under the heading it deserves: Historical amylin analogues and what happened to them Everything below is what sits behind that. I have seen SURPASS-2 ( N Engl J Med , 2021) cited in support of a…
|
+29 | 36 | 31k | 1d |
|
Tracking intake honestly when appetite is absent
On the subject in the title: Tracking intake honestly when appetite is absent Working notes rather than a conclusion. Longitudinal report with the method stated, because a number without a method is not a…
|
+109 | 115 | 4.8k | 20h |
|
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile
Posting this under the heading it deserves: Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Everything below is what sits behind that. I have seen SCALE ( N Engl J Med…
|
+115 | 122 | 2.6k | 1d |
|
Two scans six weeks apart on different machines: a cautionary tale
On the subject in the title: Two scans six weeks apart on different machines: a cautionary tale Working notes rather than a conclusion. Longitudinal report with the method stated, because a number without a…
|
+18 | 26 | 9.4k | 2mo |
|
How this community escalates rather than diagnoses — does this still hold?
The question in the title: How this community escalates rather than diagnoses — does this still hold? I will give what I have already checked below so nobody repeats it. Asking about a population rather than…
|
4 | 90 | 29d | |
|
Step therapy requirements and how to satisfy them
Posting this under the heading it deserves: Step therapy requirements and how to satisfy them Everything below is what sits behind that. A coverage question with the paperwork detail included, since that is…
|
+21 | 25 | 49k | 2mo |
|
Review: a draft on reconstitution arithmetic, with objections — one year on
Review: a draft on reconstitution arithmetic, with objections — one year on Writing it up because I had to work it out twice and would rather nobody else did. Nominating something for promotion into the…
|
+46 | 51 | 11k | 20h |
|
A community side-effect dataset, with its response rate and biases
A community side-effect dataset, with its response rate and biases — setting out what I have, and where I think it stops being reliable. Posting the method first, because I know what the first three replies…
|
2 | 5.1k | 19h | |
|
Fixed versus detachable needles: the trade-offs — does this still hold?
Fixed versus detachable needles: the trade-offs — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. A question about technique rather than about…
|
+8 | 12 | 39k | 15h |
|
What a certificate commits its issuer to — the long version
Asking directly, because I could not find a straight answer: What a certificate commits its issuer to — the long version A documentation question rather than an analytical one. I have a certificate in front…
|
+20 | 26 | 21k | 2d |
|
A 40-week log with the measurement method stated — what changed since
A 40-week log with the measurement method stated — what changed since Writing it up because I had to work it out twice and would rather nobody else did. Longitudinal report with the method stated, because a…
|
+9 | 13 | 2.1k | 9h |
|
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem
On the subject in the title: Lateral-flow and colorimetric approaches: the specificity problem Working notes rather than a conclusion. I would like to understand what this number means before I repeat it…
|
+77 | 89 | 16k | 9h |
|
Prescription requirements and telehealth models — a second dataset
On the subject in the title: Prescription requirements and telehealth models — a second dataset Working notes rather than a conclusion. A logistics question, since the answers here are usually better than…
|
+87 | 94 | 1.1k | 21d |
|
Revisiting: Spike-and-recover accuracy for a peptide assay
Revisiting: Spike-and-recover accuracy for a peptide assay — setting out what I have, and where I think it stops being reliable. I would like to understand what this number means before I repeat it anywhere.…
|
2 | 6.8k | 21h | |
|
Tesamorelin has an approved indication — what that changes about the evidence
Tesamorelin has an approved indication — what that changes about the evidence — setting out what I have, and where I think it stops being reliable. Comparing STEP 4 ( JAMA , 2021) with SURMOUNT-1 ( N Engl J…
|
+23 | 27 | 3.4k | 1d |
|
The best-written scientific paper you have read
The best-written scientific paper you have read Writing it up because I had to work it out twice and would rather nobody else did. Lower-stakes topic, but the sourcing rule still applies if anyone makes a…
|
+69 | 74 | 1.1k | 2mo |
|
Tracking semaglutide's approved indications across jurisdictions, dated
Tracking semaglutide's approved indications across jurisdictions, dated Writing it up because I had to work it out twice and would rather nobody else did. I have seen SURMOUNT-OSA ( N Engl J Med , 2024) cited…
|
+15 | 19 | 2.8k | 1d |
|
Coming back to: Why our vendor pages link the storefront and mark it sponsored
Why our vendor pages link the storefront and mark it sponsored I have a specific reason for asking rather than idle curiosity, and the context is below. Structured report rather than an opinion, following the…
|
2 | 22k | 8h | |
|
Journal club: STEP 1 and the treatment-policy estimand — does this still hold?
Asking directly, because I could not find a straight answer: Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Comparing STEP 2 ( Lancet , 2021) with SURPASS-2 ( N Engl J Med ,…
|
+70 | 76 | 4.8k | 15h |
|
Official shortage notices and what they authorise
Posting this under the heading it deserves: Official shortage notices and what they authorise Everything below is what sits behind that. Documenting an access outcome, dated, because everything in this…
|
+106 | 119 | 18k | 1mo |
|
Follow-up: Interpreting a composition change that is within the error bars
Interpreting a composition change that is within the error bars Writing it up because I had to work it out twice and would rather nobody else did. Longitudinal report with the method stated, because a number…
|
2 | 95 | 24d | |
|
Dizziness on standing: the ordinary explanation first — one year on
Dizziness on standing: the ordinary explanation first — one year on — setting out what I have, and where I think it stops being reliable. Longitudinal report with the method stated, because a number without a…
|
+12 | 16 | 1.1k | 2d |
|
List price versus negotiated price versus what you pay
On the subject in the title: List price versus negotiated price versus what you pay Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category expires.…
|
+99 | 115 | 11k | 3mo |
|
Spike-and-recover accuracy for a peptide assay
Posting this under the heading it deserves: Spike-and-recover accuracy for a peptide assay Everything below is what sits behind that. A documentation question rather than an analytical one. I have a…
|
+121 | 126 | 1.5k | 4mo |
|
Reflux appearing for the first time at a dose step
Reflux appearing for the first time at a dose step — setting out what I have, and where I think it stops being reliable. A question about technique rather than about dose. I have been doing the same thing for…
|
4 | 36k | 4mo | |
|
Semaglutide formulation: what is in the licensed product besides the peptide
Semaglutide formulation: what is in the licensed product besides the peptide — setting out what I have, and where I think it stops being reliable. Comparing LEADER ( N Engl J Med , 2016) with SURMOUNT-1 ( N…
|
+29 | 35 | 4.4k | 1h |
|
About the Insurance & coverage category
Prior authorisation, appeals, denial letters, and documentation that helps. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author and a…
|
+2 | 6 | 3.2k | 3mo |
|
GLP-1 receptor distribution: central and peripheral — one year on
GLP-1 receptor distribution: central and peripheral — one year on — setting out what I have, and where I think it stops being reliable. A documentation question rather than an analytical one. I have a…
|
+7 | 11 | 43k | 3mo |
|
Second pass at: What a 2 ppm match establishes, and what it does not
Second pass at: What a 2 ppm match establishes, and what it does not — setting out what I have, and where I think it stops being reliable. Working through the identity arithmetic and I would like it checked.…
|
+44 | 49 | 8.1k | 1d |
|
Follow-up: Sleep quality changes during weight loss
On the subject in the title: Sleep quality changes during weight loss Working notes rather than a conclusion. General question, not a request for advice about my own care — I know the difference and I would…
|
+74 | 80 | 4.4k | 14h |